 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/30/2023 |
$11.08 |
$11.30 |
$10.93 |
$11.19 |
1.27M | | 05/31/2023 |
$11.22 |
$11.50 |
$11.19 |
$11.26 |
2.19M | | 06/01/2023 |
$11.28 |
$11.54 |
$11.06 |
$11.39 |
1.23M | | 06/02/2023 |
$11.48 |
$12.20 |
$11.40 |
$12.17 |
2.47M | | 06/05/2023 |
$12.07 |
$12.37 |
$12.00 |
$12.20 |
4.25M |
|
|
| Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering medicines for diseases. Co.'s gene therapy portfolio pipeline include Pompe disease, Fabry disease, CDKL5 deficiency disorder, ceroid lipofuscinosis, neuronal, Mucopolysaccharidosis Type IIIB, as well as a program in Mucopolysaccharidosis Type IIIA. Co.'s collaboration with University of Pennsylvania also provides Co. with disease-specific access and option rights to develop new gene therapy platform technologies and programs for most lysosomal disorders and a portfolio of other rare diseases. | |
|
Amicus Therapeutics (FOLD) has the following price history information. Looking back at FOLD historical stock prices for the last five trading days, on May 30, 2023, FOLD opened at $11.08, traded as high as $11.30 and as low as $10.93, and closed at $11.19. Trading volume was a total of 1.27M shares. On May 31, 2023, FOLD opened at $11.22, traded as high as $11.50 and as low as $11.19, and closed at $11.26. Trading volume was a total of 2.19M shares. On June 01, 2023, FOLD opened at $11.28, traded as high as $11.54 and as low as $11.06, and closed at $11.39. Trading volume was a total of 1.23M shares. On June 02, 2023, FOLD opened at $11.48, traded as high as $12.20 and as low as $11.40, and closed at $12.17. Trading volume was a total of 2.47M shares. On June 05, 2023, FOLD opened at $12.07, traded as high as $12.37 and as low as $12.00, and closed at $12.20. Trading volume was a total of 4.25M shares.
FOLD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amicus Therapeutics shares, starting with a $10,000 purchase of FOLD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/07/2013 |
|
| End date: |
06/05/2023 |
|
| Start price/share: |
$3.23 |
|
| End price/share: |
$12.20 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
277.71% |
|
| Average Annual Total Return: |
14.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$37,760.81 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 05/30/2023 | $11.19 | | 05/31/2023 | $11.26 | | 06/01/2023 | $11.39 | | 06/02/2023 | $12.17 | | 06/05/2023 | $12.20 |
|
|
Free FOLD Email Alerts:
